臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 501-525 / 1137 (共46頁)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-12-02T02:34:25Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Pan-Chyr Yang; Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:22Z	From midbody protein - Protein interaction network construction to novel regulators in cytokinesis	Chen T.-C.; Lee S.-A.; Hong T.-M.; Shih J.-Y.; Lai J.-M.; Chiou H.-Y.; Yang S.-C.; Chan C.-H.; Kao C.-Y.; Pan-Chyr Yang; Huang C.-Y.F.; Chen T.-C.; PAN-CHYR YANG et al.
臺大學術典藏	2020-12-02T02:34:20Z	Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer	Wu J.-Y.;Shih J.-Y.;Yang C.-H.;Chen K.-Y.;Ho C.-C.;Yu C.-J.;Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; Ho C.-C.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:19Z	Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors	Chen K.-Y.;Chen J.-H.;Shih J.-Y.;Yang C.-H.;Yu C.-J.;Pan-Chyr Yang; Chen K.-Y.; Chen J.-H.; Shih J.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:18Z	Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer	Wu J.-Y.;Yu C.-J.;Shih J.-Y.;Yang C.-H.;Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Shih J.-Y.; Yang C.-H.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:18Z	Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma	Huang C.-T.;Yen R.-F.;Cheng M.-F.;Hsu Y.-C.;Wei P.-F.;Tsai Y.-J.;Tsai M.-F.;Shih J.-Y.;Yang C.-H.;Pan-Chyr Yang; Huang C.-T.; Yen R.-F.; Cheng M.-F.; Hsu Y.-C.; Wei P.-F.; Tsai Y.-J.; Tsai M.-F.; Shih J.-Y.; Yang C.-H.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:17Z	Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer	Wu J.-Y.;Yang C.-H.;Hsu Y.-C.;Yu C.-J.;Chang S.-H.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Yang C.-H.; Hsu Y.-C.; Yu C.-J.; Chang S.-H.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:15Z	Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women	Lu T.-P.;Tsai M.-H.;Lee J.-M.;Hsu C.-P.;Chen P.-C.;Lin C.-W.;Shih J.-Y.;Pan-Chyr Yang;Hsiao C.K.;Lai L.-C.;Chuang E.Y.; Lu T.-P.; Tsai M.-H.; Lee J.-M.; Hsu C.-P.; Chen P.-C.; Lin C.-W.; Shih J.-Y.; PAN-CHYR YANG; Hsiao C.K.; Lai L.-C.; Chuang E.Y.
臺大學術典藏	2020-12-02T02:34:13Z	Epidermal growth factor receptor mutations in small cell lung cancer: A brief report	Shiao T.-H. ;Chang Y.-L. ;Yu C.-J. ;Chang Y.-C. ;Hsu Y.-C. ;Chang S.-H. ;Shih J.-Y. ;Pan-Chyr Yang; Shiao T.-H.; Chang Y.-L.; Yu C.-J.; Chang Y.-C.; Hsu Y.-C.; Chang S.-H.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:12Z	The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma	Kuo Y.-W. ;Jerng J.-S. ;Shih J.-Y. ;Chen K.-Y. ;Yu C.-J. ;Pan-Chyr Yang; Kuo Y.-W.; Jerng J.-S.; Shih J.-Y.; Chen K.-Y.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:10Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y.;Wu S.-G.;Yang C.-H.;Chang Y.-L.;Chang Y.-C.;Hsu Y.-C.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:10Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:09Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y.;Yu C.-J.;Chang Y.-C.;Yang C.-H.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Chang Y.-C.; Yang C.-H.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:09Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Pan-Chyr Yang; Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:06Z	The EMT regulator slug and lung carcinogenesis	Shih J.-Y.;Pan-Chyr Yang; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:05Z	Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed	Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Pan-Chyr Yang; Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:04Z	Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma	Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏	2020-12-02T02:34:04Z	Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation	Lu C.-H.; Hsiao C.-H.; Chang Y.-C.; Lee J.-M.; Shih J.-Y.; Wu L.-A.; Yu C.-J.; Liu H.-M.; Shih T.T.-F.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:03Z	Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer	Su K.-Y.; Chen H.-Y.; Li K.-C.; Kuo M.-L.; Yang J.C.-H.; Chan W.-K.; Ho B.-C.; Chang G.-C.; Shih J.-Y.; Yu S.-L.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:03Z	Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment	Chung K.-P.; Huang Y.-T.; Chang Y.-L.; Yu C.-J.; Yang C.-H.; Chang Y.-C.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:03Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Wu S.-G.; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:01Z	RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer	Tsai T.-H.; Su K.-Y.; Wu S.-G.; Chang Y.-L.; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:00Z	Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial	Yang J.C.H.; Shih J.-Y.; Su W.-C.; Hsia T.-C.; Tsai C.-M.; Ou S.H.I.; Yu C.-J.; Chang G.-C.; Ho C.-L.; Sequist L.V.; Dudek A.Z.; Shahidi M.; Cong X.J.; Lorence R.M.; PAN-CHYR YANG; Miller V.A.
臺大學術典藏	2020-12-02T02:33:59Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Pan-Chyr Yang; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:33:59Z	Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors	Hsu C.-L.; Chen K.-Y.; Shih J.-Y.; Ho C.-C.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG

顯示項目 501-525 / 1137 (共46頁)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2822924
	造訪人次 : 30095358 線上人數 : 622 教育部委託研究計畫計畫執行:國立臺灣大學圖書館